The US Food and Drug Administration (FDA) approved Nourianz (istradefylline) tablets as an add─on treatment to levodopa/ carbidopa in adult patients with Parkinson’s disease (PD) experiencing “off” episodes.
The US Food and Drug Administration (FDA) approved Nourianz (istradefylline) tablets as an add─on treatment to levodopa/ carbidopa in adult patients with Parkinson’s disease (PD) experiencing “off” episodes.
Pharmamarketeer richt zich op marketingprofessionals van farmaceuten en andere medisch-gerelateerde organisaties in Nederland en België.
Copyright 2023 © Uitgave van MedHealth Communications BV | Privacy disclaimer
